Covidien Stock Price (NYSE:COV)

Add to My Stocks
$106.71 $1.36 (1.26%) COV stock closing price Jan 26, 2015 (Closing)
Prev Close* : $108.07
Market Cap:
$48.5B
Day Low: $106.71
52 Week Low: $65.97
Open: $107.97
Volume: 24887138
Day High: $108.16
52 Week High: $108.57
Dividend:
1.44

Latest Stock Market News

Latest Articles

Covidien News - From Partners

COV Stockcharts

View COV PE ratio, PS ratio stocks charts and compare with peers.
COV Chart
Note: Compare Covidien stock price history with the index and industry peers.

COV Industry Peers

Company Price Change (%)
Medtronic (MDT)75.820.73 (0.97%)
Stryker (SYK)122.550.37 (0.3%)
Becton Dickinson (BDX)173.420.07 (0.04%)
C.r. Bard (BCR)235.311.14 (0.49%)
Baxter International (BAX)46.520.07 (0.15%)
Johnson & Johnson (JNJ)114.870.27 (0.24%)
Boston Scientific (BSX)23.90.08 (0.34%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
GW Pharma (GWPH)121.791.88 (1.57%)
Fonar (FONR)20.250.3 (1.5%)
Alere (ALR)40.280.39 (0.98%)
Medtronic (MDT)75.820.73 (0.97%)
Eagle Pharma (EGRX)69.780.47 (0.68%)
Insys Therapeutics (INSY)10.30.04 (0.39%)
Boston Scientific (BSX)23.90.08 (0.34%)
Top gainers from Medical Products industry
* As of Jan 18, 2017
CompanyPriceChange (%)
TG Therapeutics (TGTX)4.60.35 (7.07%)
NanoString Technologies (NSTG)18.020.92 (4.86%)
MacroGenics (MGNX)19.350.87 (4.3%)
Rockwell Medical (RMTI)5.810.26 (4.28%)
AtriCure (ATRC)15.540.6 (3.72%)
Phibro Animal Health (PAHC)27.751 (3.48%)
LeMaitre Vascular (LMAT)23.850.85 (3.44%)
Top losers from Medical Products industry
* As of Jan 18, 2017

Covidien Financial Statements

income statement20142013201220112010
Net Sales Or Revenues10.66B10.24B11.85B11.57B10.43B
Net Income1.66B1.7B1.91B1.87B1.63B
Total Operating Expense4.34B3.95B4.4B4.2B3.74B
view Covidien plc income statement
balance sheet20142013201220112010
Total Assets20.7B19.92B22.26B20.37B20.39B
Total Liabilities10.64B10.68B11.69B10.56B11.41B
Shareholders Equity10.06B9.24B10.57B9.82B8.97B
view Covidien plc balance sheet
cash flow statement20142013201220112010
Net Increase (Decrease) In Assets Liabilities-253M-343M-232M-551M97M
Net Cash From (Used By) Operating Activities2.01B2.1B2.43B2.18B2.19B
Increase (Decrease) In Prop Plant And Equipment-353M-482M-526M-467M-401M
view Covidien plc cashflow statement

Covidien plc Stock News - Partner Headlines

David Abrams' recent trades   on Feb 23, 2015

Covidien Stock Message Board

Covidien stock lost -1.26 %, and the last close price as of 26 Jan, 2015 is 106.71 for COV stock. Looking at Covidien market capitalization, which currently stands at 48.5B, we can say that COV stock is a Large cap stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Covidien stock analysis.

Demand for a stock decides its stock market price. For example, if more investors want to buy COV stock than sell it, then Covidien stock price goes up. Conversely, if more investors wanted to sell COV stock than buy it, there would be greater supply than demand, and the stock price would fall. 24887138 shares were traded with a closing stock price of 106.71 as of 26 Jan, 2015, as can be seen from Covidien stock quote. One can view Covidien stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Covidien stock dividend was 1.44 during the last quarter. To check the historical stock price movement, all time high, and all time low of COV, view Covidien stock price history.